Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „significant“
Suchtreffer
Begriffe & Kennungen
Cresemba · 4.5 · Isavuconazole drug concentrations may significantly decrease.
Eintrag öffnenCymbalta · 4.5 · 7 substrate, were not significantly affected by co-administration with duloxetine (60 mg twice daily).
Eintrag öffnenDabigatran Etexilate Accord · 4.3 · 77 • eGFR < 50 mL/min/1.73 m2 in paediatric patients • Active clinically significant bleeding • Lesion or cond
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · 89 dabigatran etexilate twice daily had a significantly higher risk for major GI bleeds compared with warfarin
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · Subjects randomised to dabigatran etexilate 110 mg twice daily or 150 mg twice daily had a significantly lower
Eintrag öffnenDabigatran Etexilate Accord · 4.8 · Subjects randomised to dabigatran etexilate 110 mg twice daily or 150 mg twice daily had a significantly lower
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenDaptomycin Hospira · 4.5 · 8 products alter the pharmacokinetics of daptomycin. The pharmacokinetics of daptomycin were not significantly
Eintrag öffnenDeferasirox Accord · 4.5 · Cholestyramine significantly reduced the deferasirox exposure in a mechanistic study to determine the degree o
Eintrag öffnenDeferasirox Mylan · 4.5 · Cholestyramine significantly reduced the deferasirox exposure in a mechanistic study to determine the degree o
Eintrag öffnenDegevma · 4.8 · Clinically significant hypercalcaemia after treatment discontinuation has been reported in the post-marketing
Eintrag öffnenDexdor · 4.8 · Clinically significant hypotension or bradycardia should be treated as described in section 4.4.
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnenDiacomit · 4.5 · At therapeutic concentrations, stiripentol significantly inhibits several CYP450 isoenzymes: for example, CYP2
Eintrag öffnenDificlir · 4.5 · Fidaxomicin does not have a clinically significant effect on the exposure of rosuvastatin, a substrate for the
Eintrag öffnenDificlir · 4.5 · Fidaxomicin does not have a clinically significant effect on the exposure of rosuvastatin, a substrate for the
Eintrag öffnenDovato · 4.5 · Clinically significant interaction unlikely.
Eintrag öffnenDovato · 4.5 · Clinically significant interaction unlikely. Anti-infective products
Eintrag öffnen